News

After the deal on Allergan, Actavis is preparing to lay off. And focus on China

However, he did not go into the details of the possible restructuring. According to Saunders, there is overlap between the two companies in areas such as human resources and finance.
FTA Online News 
25/11/2014 International Stock Exchanges – ECONOMY THE PRESS

Actavis is preparing to reduce its workforce and expand business in China, according to as declared by the chief executive Brent Saunders to Bloomberg Television. The generics maker, which has reached an agreement to take over Allergan, the maker of Botox, in a $66 billion deal, has not, however, gone into details of the possible restructuring. According to Saunders, there is overlap between the two companies in areas such as human resources and finance.

(RR)

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Guarda anche
Close
Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco